Table 3.
Multivariate-adjusted relationship between baseline of demographic variables and blood pressure status of participants categorized by gender (N = 7119)
| Variables | Men (n = 3345) | Women (n = 3774) | ||
|---|---|---|---|---|
| Systolic blood pressure β(P-value) |
Diastolic blood pressure β (P-value) |
Systolic blood pressure β (P-value) |
Diastolic blood pressure β (P-value) |
|
| Age (years) | 0.144 (0.000) | −0.119 (0.000) | 0.224 (0.000) | −0.057 (0.011) |
| Educational levels | – | – | −0.043 (0.014) | − 0.036 (0.042) |
| Marital status | 0.081 (0.000) | 0.070 (0.000) | 0.058 (0.001) | – |
| Place of residence | 0.049 (0.004) | 0.052 (0.003) | – | – |
| Cigarette smoking | 0.048 (0.005) | – | – | – |
| Alcohol consumption | – | 0.047 (0.008) | −0.036 (0.023) | – |
| Eating habit | – | −0.055 (0.001) | – | − 0.064 (0.000) |
| Social and leisure activities | −0.034 (0.041) | – | – | – |
| Accidental injury | −0.034 (0.036) | − 0.039 (0.019) | – | – |
| Physical exercises | – | – | – | – |
| History of CVD | – | 0.034 (0.047) | – | – |
| Hepatitis history | – | – | – | −0.039 (0.015) |
| Antilipidemic therapy | – | – | – | 0.036 (0.034) |
| Antidiabetic drugs | – | −0.043 (0.021) | 0.050 (0.004) | – |
| Anti-hypertensive therapy | 0.126 (0.000) | 0.124 (0.000) | 0.097 (0.000) | 0.075 (0.000) |
| C-reactive protein (mg/l) | – | – | – | – |
| HbA1c (%) | – | – | – | – |
| Fasting plasma glucose (mg/dl) | 0.052 (0.017) | – | – | – |
| Low density lipoprotein (mg/dl) | 0.068 (0.000) | 0.050 (0.004) | – | – |
| High density lipoprotein (mg/dl) | – | – | – | – |
| eGFR (ml/min/1.73m2) | −0.091 (0.000) | −0.048 (0.035) | – | −0.045 (0.043) |
| Body mass index (kg/m2) | 0.193 (0.000) | 0.194 (0.000) | 0.129 (0.000) | 0.193 (0.000) |
| Serum uric acid (mg/dl) | 0.047 (0.013) | – | 0.040 (0.028) | – |
| Triglycerides (mg/dl) | 0.068 (0.001) | 0.064 (0.002) | 0.061 (0.002) | 0.084 (0.000) |
| R2 | 0.132 (0.000) | 0.106 (0.000) | 0.120 (0.000) | 0.081 (0.000) |